Testis tumors

Malignant germ cell and sex cord-stromal tumos of the testis click to access explanations in the original CAP template

There is separated protocol for lymphadenectomy.

Gross core data elements:

- Specimen laterality:
- Specimen focality:
- Tumor size of main tumor nodule:
- Tumor size of main tumor nodule:	- Greatest dimensions of additional tumor nodules:
- Presurgical Treatment :

+ Serum tumor markers:

+ Pre-orchiectomy serum tumor markers: Unknown Serum marker studies within normal limits Alpha-fetoprotein (AFP) elevation Beta subunit of human chorionic gonadotropin (b-hCG) elevation Lactate dehydrogenase (LDH) elevation

+ Post-orchiectomy serum tumor markers: Unknown Serum marker studies within normal limits Alpha-fetoprotein (AFP) elevation Beta subunit of human chorionic gonadotropin (b-hCG) elevation Lactate dehydrogenase (LDH) elevation

+ Serum tumor markers:

Microscopic descriptions:

- Tumor histology and immunohistochemical studies:

Histologic type (WHO 5e):

- Histologic type (intratubular germ cell neoplasia):
- Histologic type (germ cell tumors):
- Histologic type (non-choriocarcinoma trophoblastic tumor):
- Histologic type (testicular scar/regressed germ cell tumor):
- Histologic type (sex cord-stromal tumor):

- Lymphatic and / or Vascular Invasion:

+ Perineural invasion:

- Tumor extension : Germ cell neoplasia in situ only Tumor limited to testis Tumor invades rete testis Tumor invades hilar soft tissue Tumor invades epididymis Tumor invades through tunica albuginea and perforates tunica vaginalis (mesothelium) Tumor invades spermatic cord Tumor invades scrotum Tumor invades adjacent structures, rectum Tumor invades adjacent structures, other (specify): Cannot be assessed No evidence of primary tumor

Surgical margins of excision specimen:

- Spermatic cord margin:
- Other margin(s) (specify):

Regional lymph nodes:

- Histologic viability of tumor: Viable teratoma present Viable nonteratomatous tumor present No viable tumor present

- Number of regional lymph nodes examined and sites:
- Number of lymph nodes involved:
- Extranodal extension:
- Size of largest metastatic deposit (mm), specify site:
- Size of largest lymph node involved (mm), specify site:

Non-regional lymph nodes AJCC 8e pM1a:

- Histologic viability of tumor: Viable teratoma present Viable nonteratomatous tumor present No viable tumor present

- Number of non-regional lymph nodes examined and sites:
- Number of lymph nodes involved:
- Extranodal extension:
- Size of largest metastatic deposit (mm), specify site:
- Size of largest lymph node involved (mm), specify site:

Distant Metastasis: Not applicable Not identified Non-regional lymph node(s) (specify): Lung (specify): Other (specify): Cannot be determined:

Pathologic Stage Classification (AJCC 8e):

- TNM Descriptors:	m (multiple primary tumors) r (recurrent) y (post treatment)
- Primary tumor (pT) :
- Regional lymph nodes (pN):
- Distant metastasis (pM):

+ Additional pathologic findings:

Germ cell neoplasia in situ (GCNIS) Microlith Sertoli cell nodule (Pick’s adenoma) Atrophy

- Other (specify):

- Additional notes: